Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,291 | 92,046 | 108,428 | 90,427 | 136,752 |
| Marketable Securities | 197,308 | 154,724 | 156,123 | 183,749 | 165,569 |
| Receivables | 697 | 1,103 | 1,018 | 1,325 | 2,922 |
| TOTAL | $256,049 | $250,996 | $268,963 | $279,789 | $308,158 |
| Non-Current Assets | |||||
| PPE Net | 5,274 | 4,763 | 4,707 | 4,898 | 4,755 |
| Investments And Advances | 93,628 | 121,293 | 121,217 | 38,254 | 8,080 |
| Other Non-Current Assets | 3,916 | 4,295 | 4,557 | 5,460 | 5,104 |
| TOTAL | $102,818 | $130,351 | $130,481 | $48,612 | $17,939 |
| Total Assets | $358,867 | $381,347 | $399,444 | $328,401 | $326,097 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,364 | 2,100 | 2,152 | 2,108 | 1,281 |
| Accrued Expenses | 12,628 | 12,320 | 11,892 | 9,910 | 7,756 |
| Other current liabilities | 39,224 | 29,040 | 22,935 | 22,135 | 25,514 |
| TOTAL | $56,957 | $45,159 | $38,637 | $35,771 | $36,129 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,243 | 34,674 | 43,178 | 52,370 | 56,842 |
| TOTAL | $13,243 | $34,674 | $43,178 | $52,370 | $56,842 |
| Total Liabilities | $70,200 | $79,833 | $81,815 | $88,141 | $92,971 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,640 | 38,627 | 38,497 | 38,403 | 32,906 |
| Common Shares | 4 | 4 | 4 | 3 | 3 |
| Retained earnings | -190,761 | -176,748 | -158,536 | -146,954 | -136,007 |
| Other shareholders' equity | -2,804 | -712 | -50 | -4 | 0 |
| TOTAL | $288,667 | $301,514 | $317,629 | $240,260 | $233,126 |
| Total Liabilities And Equity | $358,867 | $381,347 | $399,444 | $328,401 | $326,097 |